Experimental animal studies have shown that it can protect hippocampus CA1 neurons after cerebral ischemia by downregulating TLR2/4–NFκB signaling and upregulating p38/ERK pathway [119]. The gene discussed is NFKB1; the disease is Cerebral ischemia.